Liu C - Search Results

1

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.

Qian Y, Gong Y, Fan Z, Luo G, Huang Q, Deng S, Cheng H, Jin K, Ni Q, Yu X, Liu C. Qian Y, et al. Among authors: liu c. J Hematol Oncol. 2020 Oct 2;13(1):130. doi: 10.1186/s13045-020-00958-3. J Hematol Oncol. 2020. PMID: 33008426 Free PMC article. Review.

2

Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions.

Zhang Y, Yang C, Cheng H, Fan Z, Huang Q, Lu Y, Fan K, Luo G, Jin K, Wang Z, Liu C, Yu X. Zhang Y, et al. Among authors: liu c. J Hematol Oncol. 2018 Jan 31;11(1):14. doi: 10.1186/s13045-017-0551-7. J Hematol Oncol. 2018. PMID: 29386069 Free PMC article. Review.

3

Prior history of acute pancreatitis predicts poor survival in patients with resectable pancreatic ductal adenocarcinoma.

Gong Y, Fan Z, Luo G, Huang Q, Qian Y, Cheng H, Jin K, Ni Q, Yu X, Liu C. Gong Y, et al. Among authors: liu c. Pancreatology. 2020 Jun;20(4):716-721. doi: 10.1016/j.pan.2020.02.016. Epub 2020 Feb 27. Pancreatology. 2020. PMID: 32249060

4

High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma.

Gong Y, Qian Y, Luo G, Liu Y, Wang R, Deng S, Cheng H, Jin K, Ni Q, Yu X, Wu W, Liu C. Gong Y, et al. Among authors: liu y, liu c. World J Surg Oncol. 2021 Jan 31;19(1):35. doi: 10.1186/s12957-021-02147-z. World J Surg Oncol. 2021. PMID: 33517899 Free PMC article.

5

Critical role of oncogenic KRAS in pancreatic cancer (Review).

Liu J, Ji S, Liang C, Qin Y, Jin K, Liang D, Xu W, Shi S, Zhang B, Liu L, Liu C, Xu J, Ni Q, Yu X. Liu J, et al. Among authors: liu l, liu c. Mol Med Rep. 2016 Jun;13(6):4943-9. doi: 10.3892/mmr.2016.5196. Epub 2016 Apr 27. Mol Med Rep. 2016. PMID: 27121414 Review.

6

The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer.

Guo M, Luo G, Liu C, Cheng H, Lu Y, Jin K, Liu Z, Long J, Liu L, Xu J, Huang D, Ni Q, Yu X. Guo M, et al. Among authors: liu z, liu l, liu c. Int J Mol Sci. 2016 Jul 8;17(7):1090. doi: 10.3390/ijms17071090. Int J Mol Sci. 2016. PMID: 27399694 Free PMC article.

7

Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer.

Liu Z, Jin K, Guo M, Long J, Liu L, Liu C, Xu J, Ni Q, Luo G, Yu X. Liu Z, et al. Among authors: liu l, liu c. Ann Surg Oncol. 2017 Feb;24(2):561-568. doi: 10.1245/s10434-016-5579-3. Epub 2016 Sep 20. Ann Surg Oncol. 2017. PMID: 27650825

8

The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients.

Cheng H, Luo G, Lu Y, Jin K, Guo M, Xu J, Long J, Liu L, Yu X, Liu C. Cheng H, et al. Among authors: liu l, liu c. Pancreatology. 2016 Nov-Dec;16(6):1080-1084. doi: 10.1016/j.pan.2016.09.007. Epub 2016 Sep 16. Pancreatology. 2016. PMID: 27665172

9

Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping.

Luo G, Guo M, Jin K, Liu Z, Liu C, Cheng H, Lu Y, Long J, Liu L, Xu J, Ni Q, Yu X. Luo G, et al. Among authors: liu z, liu l, liu c. Pancreatology. 2016 Nov-Dec;16(6):1057-1062. doi: 10.1016/j.pan.2016.09.013. Epub 2016 Sep 23. Pancreatology. 2016. PMID: 27692554

10

CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtype.

Luo G, Liu C, Guo M, Long J, Liu Z, Xiao Z, Jin K, Cheng H, Lu Y, Ni Q, Yu X. Luo G, et al. Among authors: liu z, liu c. Cancer Lett. 2017 Jan 28;385:46-50. doi: 10.1016/j.canlet.2016.10.046. Epub 2016 Nov 10. Cancer Lett. 2017. PMID: 27840089

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73,620 results

Search Page